Browsing: GLP-1 medications

Wegovy Enters Chinese Market, Targeting Obesity Epidemic

By 0

Novo Nordisk launches Wegovy in China, targeting the country’s 180 million people with obesity. Priced at ¥1,400 ($192 USD) per starter dose, it faces accessibility challenges as it’s not covered by national insurance. The move heightens competition with Eli Lilly.